"Scaling AI like a tech native" ... new perspective from my colleague Nayur Khan and others. Worth a read. And here is the aspiration or challenge: how to implement MLOps at scale in biotech/biopharma R&D ... making the #BioRevolution happen. mckinsey.ds8.io/n893Uq1meE

Chinese biopharma is making a mark on the global stage as the rapidly evolving regulatory landscape and maturing innovation ecosystem spur value creation - see new articles from our biotech experts in China. #Biotech #China mckinsey.ds8.io/NeCsD3G2QS

Excited about this list of 22 technologies to watch from The Economist - quite some from the bio & tech confluence-driven #TheBioRevolution - like brain interfaces, personalized nutrition and many more. mckinsey.ds8.io/6VQ1SwWKcT

If you are curious about #TheBioRevolution - new piece on the third wave of biomaterials. Congrats and thanks to the authors! mckinsey.ds8.io/Tk-htY7uq4

New article on why integration matters in evidence generation strategies in drug R&D. #Innovation mckinsey.ds8.io/x-Fcv3MK5b

Citing MGI's research, WEF notes that the Bio Revolution could be an enormous boon to the economy in the decades to come. #BioRevolution mckinsey.ds8.io/cjabK2P9NK

And here it is ... MIT's "10 Breakthrough Technologies 2021" ... an annual must-read to avoid missing the pace of innovation. mRNA obviously prominently featured. #Innovation #BioRevolution mckinsey.ds8.io/KFJKkWE0wq

The roadmap towards a #data-driven enterprise by 2025 - a big theme for the years to come: mckinsey.ds8.io/0T8bejxFpc mckinsey.ds8.io/TTbA3u-ggR

What would shift to net-zero by 2050 entail? New McKinsey research lays out the six defining characteristics of the net-zero transition. Watch this video to learn more, and download the full report here: mckinsey.ds8.io/banBcbQ06X mckinsey.ds8.io/J06sP7Wec-

It is true. After the lab, 20 years at McKinsey & Company focused on innovation and R&D in life sciences across the globe - I will join Evotec as Chief Business Officer (BD, tech, strategy) as of May 1. For now I will stay committed to my clients & mission but stay tuned, more to come.

New paper on how harnessing advances in science and technology can deliver transformative therapies faster while reducing the socioeconomic burden of disease. #pipelinebuilding #socioeconomic #health4people mckinsey.dsmn8.com/5M4XSJexpT

Today is my last day at McKinsey & Company. I joined out of curiosity and for the professional challenges, stayed for the people, and leave with amazing memories and deep friendships. Thank you all - onwards and upwards :)

Hello world! I am excited to start my journey with Evotec as of today - together with all my new colleagues and all our partners driving innovation for the benefit of patients across the world. Let’s make a it count!

AI has made great strides in recent years, enabling the processing of large amounts of data in a short time frame. In this publication Evotec experts review state-of-the-art #AI methods being applied to #drugdiscovery. - hubs.ly/Q019CfLM0 #researchneverstops

It's launch day ... with PanHunter from patient-driven disease understanding to new therapies. evotec.com/en/investor-re…

Being in there for the mission and the fun of it.

Imagine the last five years without this. reddit.com/gallery/1h5ggou

Congrats. Zavain Dar & Team!